✦ LIBER ✦

Platelets hemostasis in chronic viral liver diseases during interferon treatment

✍ Scribed by Pavel Koroy; Alexandre Yagoda

Book ID: 118565321
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 112 KB
Volume: 36
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(02)80405-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum lipid profiles during interferon t

Serum lipid profiles during interferon treatment in patients with chronic viral hepatitis

✍ S. Karatapanis; I. Keticoglou; S. Georgopoulos; A. Natsios; L. Papakonstantinou; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 89 KB

P-303 Mechanism of the changes of platel

P-303 Mechanism of the changes of platelet counts during interferon therapy in HCV-positive chronic liver disease (CLD)

✍ K Azuma; E Kajiwara; K Onoyama; K Akagi; M Fujishima 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 128 KB

The liver-cytokine-brain circuit in inte

The liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis

✍ C. Stasi; A. L. Zignego; G. Laffi; M. Rosselli 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

Hepatitis C viremia in chronic liver dis

Hepatitis C viremia in chronic liver disease: Relationship to interferon-α or corticosteroid treatment

✍ Dr. Silvio Magrin; Antonio Craxi; Carmelo Fabiano; Rosa Giovanna Simonetti; Germ 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 638 KB

942 VIRAL KINETIC MODELING DURING TREATM

942 VIRAL KINETIC MODELING DURING TREATMENT WITH INTERFERON LAMBDA-1A IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

✍ M.G. Dodds; D.F. Hausman; D.M. Miller 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Activation of liver disease in healthy h

Activation of liver disease in healthy hepatitis B surface antigen carriers during interferon-alpha treatment

✍ Rodríguez-Iñigo, Elena; Bartolomé, Javier; López-Alcorocho, Juan Manuel; Cotonat 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

Fifty percent of healthy hepatitis B surface antigen carriers may have histologically proven chronic hepatitis. Our aim was to study the benefit of interferon-alpha in healthy patients. Twenty-nine hepatitis B surface antigen carriers with normal liver enzymes and with serum hepatitis B virus DNA we